STOCK TITAN

RAPP (NASDAQ: RAPP) insider sale reported: 2,840 common shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

RAPP filed a Form 144 reporting proposed resale activity in its Common Stock. The filing lists an offering date of 05/20/2025 and a filing marker of 03/25/2026. The excerpt shows a reported sale of 2,840 Common shares on 12/31/2025 for $85,342.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does RAPP's Form 144 disclose about the transaction?

The Form 144 discloses a reported sale of 2,840 Common shares on 12/31/2025. It also lists an offering date of 05/20/2025 and a filing marker dated 03/25/2026, with proceeds shown as $85,342.

What dates are shown on the RAPP Form 144 excerpt?

The excerpt shows an offering date of 05/20/2025, a reported sale date of 12/31/2025, and a filing marker of 03/25/2026. Those dates appear adjacent to the security and transaction lines in the provided content.

How much cash consideration is shown for the shares in RAPP's filing?

The filing excerpt shows aggregate proceeds of $85,342 tied to the reported sale of 2,840 Common shares on 12/31/2025. The excerpt pairs the share count and dollar amount on the sale line.
Rapport Therapeutics Inc

NASDAQ:RAPP

View RAPP Stock Overview

RAPP Rankings

RAPP Latest News

RAPP Latest SEC Filings

RAPP Stock Data

1.50B
44.92M
Biotechnology
Pharmaceutical Preparations
Link
United States
BOSTON